These emerging therapies , Tirzepatide , represent a remarkable advancement in treating metabolic dysfunction and potentially associated ailments . These drugs are categorized as GLP-1 hormone agonists , indicating they function to replicate the natural GLP-1 peptide, boosting insulin release and reducing appetite . Although Retatrutide each one wo